References
- Pistosis C, Demoly P, Bilo MB, Gerth van Wijk R, Pfaar O, Sturm GJ, Rodriguez Del Rio P, Tsoumani M, Gawlik R, Paraskevopoulos G, Ruëff F, Valovirta E, Papadopoulos NG, et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy 2015; 70:897-909:PMID:25913519; http://dx.doi.org/10.1111/all.12638
- Zuberbier T, Bachert C, Bousquet PJ, Passalacqua G, Walter Canonica G, Merk H, Worm M, Wahn U, Bousquet J. GA2; LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy 2010; 65(12):1525-30; PMID:21039596; http://dx.doi.org/10.1111/j.1398-9995.2010.02474.x
- Linneberg A, Madsen F, Skaaby T. Allergen-specific immunotherapy and risk of autoimmune disease. Curr Opin Allergy Clin Immunol 2012; 12:635-9; PMID:22914311; http://dx.doi.org/10.1097/ACI.0b013e3283588c8d
- Sequiera JF, Cesic D, Keser G, Bukelica M, Karanagnostis S, Khamashta MA, Hughes GR. Allergic disorders in systemic lupus erythematosus. Lupus 1993; 2:187-99; PMID:8369810; http://dx.doi.org/10.1177/096120339300200311
- Taylor RJ. Hypersensitivity vasculitis occurring in a patient receiving immunotherapy. J Allergy Clin Immunol 1991; 87:889-90; PMID:1826508; http://dx.doi.org/10.1016/0091-6749(91)90139-F
- Maciel BM, Morfin BM. Specific immunotherapy-related scleroderma. Case Report Rev Alerg Mex 2009; 56:135-44
- Turkcapar N, Kiniklui G, Sak SD, Duman M. Specific immunotherapy-induced Sjogren's syndrome. Rheumatol Int 2005; 26:182-4; PMID:15965636; http://dx.doi.org/10.1007/s00296-005-0606-x
- International Classification of Disease, the 10th revision. 2010. Available at http://apps.who.int/classifications/icd10/browse/2010/en ( available 12.01.2010).
- Bozek A, Kozlowska R, Jarzab J. The safety of specific immunotherapy for patients allergic to house-dust mites and pollen in relation to the development of neoplasia and autoimmune disease: a long-term, observational case-control study. Int Arch Allergy Immunol 2014; 163:307-12; PMID:24776522; http://dx.doi.org/10.1159/000361022
- Calderon MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and byond. J Allergy Clin Immunol 2011; 127:30-8; PMID:20965551; http://dx.doi.org/10.1016/j.jaci.2010.08.024
- Linnberg A, Jacobsen RK, Jespersen L, Abildstrom SZ. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischaemic heart disease, and morality. J Allergy Clin Immunol 2012; 129:413-9; PMID:22004944; http://dx.doi.org/10.1016/j.jaci.2011.09.007
- Gołąb J, Jakóbisiak M, Lasek W, Stokłosa T. Immunologia. Golab J (Ed.), Warszawa: PWN, 2008.
- Bachelet I, Levi-Schaffer F, Mekori YA. Mast cells: not only in allergy. Immunol Allergol North Am 2006; 26(3):407-25; PMID: NOT_FOUND; http://dx.doi.org/10.1016/j.iac.2006.05.007
- Robinson DS. The role of the T-cell in asthma. J Allergy Clin Immunol 2010; 126(6):1081-91; PMID:20709383; http://dx.doi.org/10.1016/j.jaci.2010.06.025
- Robinson KM, Manni ML, Biswas PS, Alcorn JF. Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders. Curr Allergy Asthma Rep 2013; 13(6):587-95; PMID:23760974; http://dx.doi.org/10.1007/s11882-013-0361-0
- Lindelof B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and autoimmune disease: a registry-based study. Clin Exp Allergy 2009; 39:110-5; PMID:19068101; http://dx.doi.org/10.1111/j.1365-2222.2008.03115.x